Recent advancements in stem cell technology open a new door for patients suffering from
diseases and disorders that have yet to be treated. Stem cell-based therapy, including …

Alzheimer's disease (AD) is the most common form of dementia worldwide, with a complex,
poorly understood pathogenesis. Cerebral atrophy, amyloid-β (Aβ) plaques, and …

Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) transplantation is a
promising therapy for Alzheimer's disease (AD). However, hUC-MSCs cultured in vitro easily …

The nervous system is a crucial part of the human body that is damaged by traumatic injury,
stroke, and neurodegenerative diseases. Recent studies also have shown that …

Huntington's disease (HD) is a neurological disorder characterized by a reduction in
medium-spiny neurons in the brain. Currently, there is no cure for HD and treatment relies …

Background Transplantation of stem cells for treating neurodegenerative disorders is a
promising future therapeutic approach. However, the molecular mechanism underlying the …

Stem cell therapy is a promising and rapidly advancing treatment strategy for a multitude of
neurologic disorders. Yet, while early phase clinical trials are being pursued in many …

Traditional therapeutic approaches in the treatment of cancer have many side effects and
are often ineffective and non-specific, leading to the development of therapy-resistant …

Alzheimer's disease (AD) is a complex form of neurodegenerative dementia. Growing body
of evidence supports the cardinal role of sirtuin1 (SIRT1) in neurodegeneration and AD …

McArdle disease is a rare autosomal recessive disorder caused by mutations in the PYGM
gene. This gene encodes for the skeletal muscle isoform of glycogen phosphorylase …